TCL Archive Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer September 26, 2008
TCL Archive Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate April 25, 2014
TCL Archive Guest Commentary: Donald Berry Finds Fundamental Flaws In Data Pooling Plan. November 16, 2007
TCL Archive Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group August 13, 1976